11: Urinary Tract Infections Flashcards
1
Q
Define a urinary tract infection.
A
- Significant bacteriuria in presence of constellation of symptoms:
- Dysuria (painful urination)
- Increased urinary frequency/urgency
- Suprapubic discomfort
- Costovertebral angle tenderness
-
Lower UTI (acute cystitis, urethritis, prostatitis): infx of bladder/urethra; sx = dysuria, suprapubic tenderness, urinary frequency/urgency, low back pain, bladder fullness/discomfort, hemorrhagic cystitis (10%)
- If sexually active woman, must rule out gonorrheal/chlamydial urethritis, especially if sx of vaginal discharge
- Upper UTI (acute pyelonephritis, intra-renal abscess, perinephric absecc): infx in kidney and renal pelvis; sx = flank pain, fever, sweating, dehydration, hypotension, dysuria, urinary urgency/frequency
2
Q
Distinguish complicated vs. uncomplicated UTI.
A
- Uncomplicated: absence of known predisposing conditions; infection in structurally and neurologically normal urinary tract; simple cystitis of 1-5 day duration.
- Complicated: occur in patients w/ underlying, predisposing condition (medical, functional, anatomic) that increases risk of initial infection and recurrence; reduces therapy efficacy; more abx-resistance
3
Q
Give the epidemiology of UTI’s.
A
- Increased risk:
- Neonates (males)
- Prepubertal girls
- Young women
- Older men
- Structural abnormalities of UT
- Immunosuppresion (diabetes)
- In sexually active women, mostly caused by E. Coli or Staph saprophyticus.
- In catheterized patients, GP organisms (Enterococcus spp) and coag-neg staph more common.
4
Q
Describe the pathogenesis of UTIs.
A
- Hematogenous Route: Infx of renal parenchyma by blood-borne organisms; kidney abscess in pt w/ bacteremia or endocarditis caused by GP S. aureus.
-
Ascending Route
- Colonization of periurethral area with uropathogenic bacteria (fecal flora)
- Urethral colonization
- Bladder inoculation
- Cystitis, urethritis
- Pyelonephritis
5
Q
Describe the bacterial virulence factors.
A
- Enhanced adherence to receptors on uroepithelial cells: Type 1 fimbriae, P fimbriae
- Phase variation: Type 1 fimbriae = facilitate attachment to bladder epithelium but phagocytosed, P fimbriae = block phagocytosis, expressed in renal parenchyma; in upper UTIs, Type 1 downreg’d, Type P upreg’d.
- Flagella: enhanced motility
- Hemolysin: pore formation in cells –> cell lysis –> nutrient release
- Aerobactin (siderophore): iron acquisition in otherwise iron-poor environment of UT
6
Q
Describe the diagnosis of UTIs.
A
- Urinalysis: presence of WBCs (pyuria), RBCs (hematuria), bacteria (bacteriuria)
- In sexually active young women, presence of pyuria, hematuria or bacteriuria highly suggestive of UTI; diagnose cystitis w/o urine culture
- >10 leukocytes/microliter urine indicates infection
- Urine dipstick test: leukocyte esterase + (pyuria), nitrite + in 25% (bacteria)
- Urine leukocyte esterase test: rapid screen for pyuria, nitrite
- Microbiological analysis = gold standard
- Bacteria > 105/mL urine indicates infection
- Proteinuria suggests complicated cystitis or upper UTI
- Low margin of error in Rx for children, pregnant women
- Radiographic studies (ultrasound, IV pyelography, CT) for pts with abnormalities of UT, suspected abscess, pt with pyelonephritis that does not respond within 72 hours
7
Q
Describe the treatment of UTIs.
A
- Lower UTI in health female with sx of recent onset: oral abx for 3 days; all other women, 5-7 days
- For acute pyelonephritis: IV w/ completion PO after afebrile (total duration 10-14 days); repeat urine culture 5-9 days post-therapy (if positive, Rx 2-4 weeks)
- TMP-SMZ (Bactrim) & fluoroquinolones (cipro/levofloxacin) ideal agents
8
Q
Describe candiduria.
A
- Presence of candida (fungus) in urine.
- Seen primarily in catheterized pts, often asymptomatic.
- Rx for infx that do not resolve post-catheter: oral fluconazole, bladder irrigation w/ ampB